Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Ethanolamine-phosphate cytidylyltransferase is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
PCYT2 |
Gene ID: |
5833 |
Uniprot ID: |
PCY2_HUMAN |
Specificity: |
This antibody detects endogenous levels of PCYT2 at Human, Mouse, Rat |
Immunogen: |
Synthesized peptide derived from human PCYT2 |
Function | Ethanolamine-phosphate cytidylyltransferase that catalyzes the second step in the synthesis of phosphatidylethanolamine (PE) from ethanolamine via the CDP-ethanolamine pathway. Phosphatidylethanolamine is a dominant inner-leaflet phospholipid in cell membranes, where it plays a role in membrane function by structurally stabilizing membrane-anchored proteins, and participates in important cellular processes such as cell division, cell fusion, blood coagulation, and apoptosis. |
Protein Name | Ethanolamine-Phosphate CytidylyltransferaseCtp -Phosphoethanolamine CytidylyltransferasePhosphorylethanolamine Transferase |
Database Links | Reactome: R-HSA-1483213 |
Alternative Antibody Names | Anti-Ethanolamine-Phosphate Cytidylyltransferase antibodyAnti-Ctp -Phosphoethanolamine Cytidylyltransferase antibodyAnti-Phosphorylethanolamine Transferase antibodyAnti-PCYT2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance